RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
TRPIX
Price
$46.15
Change
-$0.07 (-0.15%)
Updated
Jun 5 closing price
Net Assets
29.46B
Interact to see
Advertisement

RMEBX vs TRPIX

Header iconRMEBX vs TRPIX Comparison
Open Charts RMEBX vs TRPIXBanner chart's image
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
T. Rowe Price Value I
Price$46.15
Change-$0.07 (-0.15%)
VolumeN/A
Net Assets29.46B
RMEBX vs TRPIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMEBX vs. TRPIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and TRPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. TRPIX (29.5B). TRPIX (1.21) and RMEBX (1.16) have matching dividends . RMEBX was incepted earlier than TRPIX: RMEBX (11 years) vs TRPIX (10 years). RMEBX (1.07) is less costly to investors than TRPIX (0.58). TRPIX is a more actively managed with annual turnover of: 59.50 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than TRPIX: RMEBX (250) vs TRPIX (500000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. TRPIX (0.62). RMEBX return over 5 years is better than : 49.85 vs. TRPIX (39.76).
RMEBXTRPIXRMEBX / TRPIX
Total Expense Ratio1.070.57188%
Annual Report Gross Expense Ratio1.070.58184%
Fund Existence11 years10 years-
Gain YTD5.3493.982134%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets105B29.5B356%
Annual Yield % from dividends1.161.2196%
Returns for 1 year8.300.621,334%
Returns for 3 years17.9610.81166%
Returns for 5 years49.8539.76125%
Returns for 10 years68.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA